AAAAAA
Results:
1-24
|
Results: 24
Authors:
STOYANOVSKY DA
WU DF
CEDERBAUM AI
Citation: Da. Stoyanovsky et al., INTERACTION OF 1-HYDROXYETHYL RADICAL WITH GLUTATHIONE, ASCORBIC-ACIDAND ALPHA-TOCOPHEROL, Free radical biology & medicine, 24(1), 1998, pp. 132-138
Authors:
PARDRIDGE WM
WU DF
SAKANE T
Citation: Wm. Pardridge et al., COMBINED USE OF CARBOXYL-DIRECTED PROTEIN PEGYLATION AND VECTOR-MEDIATED BLOOD-BRAIN-BARRIER DRUG-DELIVERY SYSTEM OPTIMIZES BRAIN UPTAKE OFBRAIN-DERIVED NEUROTROPHIC FACTOR FOLLOWING INTRAVENOUS ADMINISTRATION, Pharmaceutical research, 15(4), 1998, pp. 576-582
Authors:
WU DF
ZHOU X
YANG GL
XIE YT
HU MB
WU ZQ
YANG G
LU MX
Citation: Df. Wu et al., CLINICAL-PERFORMANCE OF THE AMDL DR-70(TM) IMMUNOASSAY KIT FOR CANCER-DETECTION, Journal of immunoassay, 19(1), 1998, pp. 63-72
Authors:
TSUKAMOTO H
HAMADA Y
WU DF
BOADO RJ
PARDRIDGE WM
Citation: H. Tsukamoto et al., GLUT1 GLUCOSE-TRANSPORTER - DIFFERENTIAL GENE-TRANSCRIPTION AND MESSENGER-RNA BINDING TO CYTOSOLIC AND POLYSOME PROTEINS IN BRAIN AND PERIPHERAL-TISSUES, Molecular brain research, 58(1-2), 1998, pp. 170-177
Authors:
WU DF
PARDRIDGE WM
Citation: Df. Wu et Wm. Pardridge, PHARMACOKINETICS AND BLOOD-BRAIN-BARRIER TRANSPORT OF AN ANTITRANSFERRIN RECEPTOR MONOCLONAL-ANTIBODY (OX26) IN RATS AFTER CHRONIC TREATMENT WITH THE ANTIBODY, Drug metabolism and disposition, 26(9), 1998, pp. 937-939
Authors:
PARDRIDGE WM
BUCIAK J
YANG J
WU DF
Citation: Wm. Pardridge et al., ENHANCED ENDOCYTOSIS IN CULTURED HUMAN BREAST-CARCINOMA CELLS AND IN-VIVO BIODISTRIBUTION IN RATS OF A HUMANIZED MONOCLONAL-ANTIBODY AFTER CATIONIZATION OF THE PROTEIN, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 548-554
Authors:
WU DF
RAMIN SA
CEDARBAUM AI
Citation: Df. Wu et al., EFFECT OF PYRIDINE ON THE EXPRESSION OF CYTOCHROME-P450 ISOZYMES IN PRIMARY RAT HEPATOCYTE CULTURE, Molecular and cellular biochemistry, 173(1-2), 1997, pp. 103-111
Authors:
WU DF
KANG YS
BICKEL U
PARDRIDGE WM
Citation: Df. Wu et al., BLOOD-BRAIN-BARRIER PERMEABILITY TO MORPHINE-6-GLUCURONIDE IS MARKEDLY REDUCED COMPARED WITH MORPHINE, Drug metabolism and disposition, 25(6), 1997, pp. 768-771
Authors:
SHIN SU
WU DF
RAMANATHAN R
PARDRIDGE WM
MORRISON SL
Citation: Su. Shin et al., FUNCTIONAL AND PHARMACOKINETIC PROPERTIES OF ANTIBODY-AVIDIN FUSION PROTEINS, The Journal of immunology, 158(10), 1997, pp. 4797-4804
Authors:
WU DF
YANG J
PARDRIDGE WM
Citation: Df. Wu et al., DRUG TARGETING OF A PEPTIDE RADIOPHARMACEUTICAL THROUGH THE PRIMATE BLOOD-BRAIN-BARRIER IN-VIVO WITH A MONOCLONAL-ANTIBODY TO THE HUMAN INSULIN-RECEPTOR, The Journal of clinical investigation, 100(7), 1997, pp. 1804-1812
Authors:
WU DF
OTTON SV
INABA T
KALOW W
SELLERS EM
Citation: Df. Wu et al., INTERACTIONS OF AMPHETAMINE ANALOGS WITH HUMAN LIVER CYP2D6, Biochemical pharmacology, 53(11), 1997, pp. 1605-1612
Authors:
HUWYLER J
WU DF
PARDRIDGE WM
Citation: J. Huwyler et al., BRAIN DRUG-DELIVERY OF SMALL MOLECULES USING IMMUNOLIPOSOMES, Proceedings of the National Academy of Sciences of the United Statesof America, 93(24), 1996, pp. 14164-14169
Authors:
WU DF
CEDERBAUM AI
Citation: Df. Wu et Ai. Cederbaum, EXPRESSION OF CYTOCHROME P4502E1 IN RAT FETAL HEPATOCYTE CULTURE, Molecular pharmacology, 49(5), 1996, pp. 802-807
Authors:
WU DF
PARDRIDGE WM
Citation: Df. Wu et Wm. Pardridge, CENTRAL-NERVOUS-SYSTEM PHARMACOLOGICAL EFFECT IN CONSCIOUS RATS AFTERINTRAVENOUS-INJECTION OF A BIOTINYLATED VASOACTIVE-INTESTINAL-PEPTIDEANALOG COUPLED TO A BLOOD-BRAIN-BARRIER DRUG-DELIVERY SYSTEM, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 77-83
Authors:
WU DF
BOADO RJ
PARDRIDGE WM
Citation: Df. Wu et al., PHARMACOKINETICS AND BLOOD-BRAIN-BARRIER TRANSPORT OF [H-3] BIOTINYLATED PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE CONJUGATED TO A VECTOR-MEDIATED DRUG-DELIVERY SYSTEM, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 206-211
Authors:
WU DF
CEDERBAUM AI
Citation: Df. Wu et Ai. Cederbaum, ETHANOL CYTOTOXICITY TO A TRANSFECTED HEPG2 CELL-LINE EXPRESSING HUMAN CYTOCHROME P4502E1, The Journal of biological chemistry, 271(39), 1996, pp. 23914-23919
Authors:
BOADO RJ
KANG YS
WU DF
PARDRIDGE WM
Citation: Rj. Boado et al., RAPID PLASMA-CLEARANCE AND METABOLISM IN-VIVO OF A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE WITH A SINGLE, INTERNAL PHOSPHODIESTER BOND, Drug metabolism and disposition, 23(11), 1995, pp. 1297-1300
Authors:
WU DF
OTTON SV
KALOW W
SELLERS EM
Citation: Df. Wu et al., EFFECTS OF ROUTE OF ADMINISTRATION ON DEXTROMETHORPHAN PHARMACOKINETICS AND BEHAVIORAL-RESPONSE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1431-1437
Authors:
WU DF
CEDERBAUM AI
Citation: Df. Wu et Ai. Cederbaum, CHARACTERIZATION OF PYRAZOLE AND 4-METHYLPYRAZOLE INDUCTION OF CYTOCHROME P4502E1 IN RAT-KIDNEY, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 407-413
Authors:
CARROCCIO A
WU DF
CEDERBAUM AI
Citation: A. Carroccio et al., ETHANOL INCREASES CONTENT AND ACTIVITY OF HUMAN CYTOCHROME P4502E1 INA TRANSDUCED HEPG2 CELL-LINE, Biochemical and biophysical research communications, 203(1), 1994, pp. 727-733
Authors:
WU DF
CEDERBAUM AI
Citation: Df. Wu et Ai. Cederbaum, ETHANOL-CONSUMPTION BY THE NURSING MOTHER INDUCES CYTOCHROME P-4502E1IN NEONATAL RAT-LIVER, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 560-566
Authors:
WU DF
OTTON SV
MORROW P
INABA T
KALOW W
SELLERS EM
Citation: Df. Wu et al., HUMAN HEPATIC CYTOCHROME-P450 2D6-LIKE ACTIVITY IN NONHUMAN-PRIMATES - CATALYTIC CHARACTERIZATION IN-VITRO, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 715-719
Authors:
WU DF
REIDENBERG MM
Citation: Df. Wu et Mm. Reidenberg, EFFECT OF POTASSIUM-DEFICIENCY AND GOSSYPOL ON URINARY N-ACETYL-BETA-GLUCOSAMINIDASE EXCRETION IN THE RAT, Contraception, 48(5), 1993, pp. 513-516
Authors:
OTTON SV
WU DF
JOFFE RT
CHEUNG SW
SELLERS EM
Citation: Sv. Otton et al., INHIBITION BY FLUOXETINE OF CYTOCHROME-P450 2D6 ACTIVITY, Clinical pharmacology and therapeutics, 53(4), 1993, pp. 401-409
Risultati:
1-24
|